UnknownNot applicableNCT05667428
A Multicenter Open-label Clinical Study on the Prevention of Premature Ovarian Failure After HSCT
Studying Complications after hematopoietic stem cell transplantation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- Principal Investigator
- Xiaoning Wang, MD, M.DFirst Affiliated Hospital Xi'an Jiaotong University
- Intervention
- leuprorelin(drug)
- Enrollment
- 200 enrolled
- Eligibility
- 18-45 years · FEMALE
- Timeline
- 2023 – 2025
Study locations (1)
- First Affiliated Hospital of Xian Jiaotong University, Xi'an, Shaanxi, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05667428 on ClinicalTrials.govOther trials for Complications after hematopoietic stem cell transplantation
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06625372Comparison of Intralipid With SMOF Lipid Following HSCTShahid Beheshti University
- RECRUITINGNANCT06241274Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCTUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology
- RECRUITINGNANCT06198517Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCTYi Zhang
See all trials for Complications after hematopoietic stem cell transplantation →